Acute promyelocytic leukemia in a child with reticulin fibrosis
Tóm tắt
Reactive myelofibrosis (MF) may be associated with infectious, inflammatory, or neoplastic conditions. Extensive myelofibrosis and indolent course are frequent in acute megakaryoblastic leukemia, but these findings are rarely reported in acute promyelocytic leukemia (APL). Patients with neoplastic disorders associated with MF are reported to have an inferior outcome. However, the effect of this association is not apparent in APL patients. This report presents a case of APL in a pediatric patient in association with significant reticulin fibrosis and osteosclerosis. The case highlights that fibrosis in the marrow can make it more challenging to diagnose acute leukemia. The PML-RARA transcripts can be present with subtle clinical or hematological findings, emphasizing the importance of molecular studies in unexplained cytopenias. Furthermore, in the case of APL, as opposed to other myeloid neoplasms, fibrosis does not appear to be associated with a worse prognosis and can resolve after treatment.
Tài liệu tham khảo
Kuter DJ, Bain B, Mufti G, Bagg A, Hasserjian RP (2007) Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol 139(3):351–362
Bae E, Park CJ, Cho YU, Seo EJ, Chi HS, Jang S, Lee KH, Lee JH, Lee JH, Suh JJ, Im HJ (2013) Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis. Int J Lab Hematol 35(6):629–636
Conneely SE, Stevens AM (2020) Advances in pediatric acute promyelocytic leukemia. Children (Basel) 7(2):11
Aksu T, Fettah A, Bozkaya İO, Baştemur M, Kara A, Çulha VK, Özbek NY, Yaralı N (2018) Acute promyelocytic leukemia in children: a single centre experience from Turkey. Mediterr J Hematol Infect Dis 10(1):e2018045
Abou Dalle I, Nassif S, Bazarbachi A (2018) Acute promyelocytic leukemia with increased bone marrow reticulin fibrosis: description of three cases and review of the literature. Hematol Oncol Stem Cell Ther 11(2):99–104
Mori A, Wada H, Okada M, Takatsuka H, Tamura A, Fujimori Y, Okamoto T, Takemoto Y, Kanamaru A, Kakishita E (2000) Acute promyelocytic leukemia with marrow fibrosis at initial presentation: possible involvement of transforming growth factor-beta(1). Acta Haematol 103(4):220–223
Sinigaglia R, Gigante C, Bisinella G, Varotto S, Zanesco L, Turra S (2008) Musculoskeletal manifestations in pediatric acute leukemia. J Pediatr Orthop 28(1):20–28
Gianelli U, Vener C, Bossi A, Cortinovis I, Iurlo A, Fracchiolla NS, Savi F, Moro A, Grifoni F, De Philippis C, Radice T, Bosari S, Lambertenghi Deliliers G, Cortelezzi A (2012) The European consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis. Mod Pathol 25(9):1193–1202
Buesche G, Ganser A, Schlegelberger B, von Neuhoff N, Gadzicki D, Hecker H, Bock O, Frye B, Kreipe H (2007) Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia. Leukemia 21(12):2420–2427
Ramos F, Robledo C, Izquierdo-García FM, Spanish Group for Myelodysplastic Syndromes (GESMD) et al (2016) Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis. Oncotarget 7(21):30492–30503
Wu Z, Chen R, Wu L, Zou L, Ding F, Wang M, Liu X (2017) Bone marrow fibrosis at diagnosis predicts survival for primary acute myeloid leukemia. Clin Transl Oncol 19(12):1462–1468
Norén-Nyström U, Roos G, Bergh A, Botling J, Lönnerholm G, Porwit A, Heyman M, Forestier E (2008) Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome. Leukemia 22(3):504–510. https://doi.org/10.1038/sj.leu.2405072
Losada R, Cabrera H, Hernández P, Hernández C, Menéndez A, Mesa J, Plascencia A, Ramón L, Agramonte O, Espinosa E (2002) Bone marrow reticulin fibrosis at diagnosis in promyelocytic leukaemia treated with all-trans retinoic acid has no adverse prognosis. Acta Haematol 108(2):111–112
Shah H, Bradford C, Sayar H (2015) Acute promyelocytic leukemia presenting with severe marrow fibrosis. Case Rep Hematol 2015:826894
Lu Q, Chen Y, Li Z (2012) Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine. Leuk Res 36(6):e119–e121
Fukuno K, Tsurumi H, Yoshikawa T, Yamada T, Oyama M, Moriwaki H (2001) A variant form of acute promyelocytic leukemia with marked myelofibrosis. Int J Hematol 74(3):322–326
Dutta P, Hasan S, Bhattacharyya J, Kumar R, Mahapatra M, Saxena R, Tyagi S, Sazawal S, Pati HP (2006) Acute promyelocytic leukemia with secondary myelofibrosis -- case report and review of the literature. Am J Hematol 81(6):476–477
Aventín A, Mateu R, Martino R, Colomer D, Bordes R (1998) A case of cryptic acute promyelocytic leukemia. Leukemia 12(9):1490–1491